A detailed history of Verition Fund Management LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 11,710 shares of ANIK stock, worth $287,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,710
Holding current value
$287,129
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.57 - $28.47 $287,714 - $333,383
11,710 New
11,710 $296,000
Q3 2023

Nov 14, 2023

BUY
$16.98 - $26.1 $275,279 - $423,133
16,212 New
16,212 $302,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.